# Infiltration of Medical Ozone for the Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ)

> **NCT05036837** · PHASE1,PHASE2 · SUSPENDED · sponsor: **University of Palermo** · enrollment: 50 (actual)

## Conditions studied

- MEDICATION RELATED OSTEONECROSIS OF THE JAW

## Interventions

- **DRUG:** OZOPROMAF_SEQ1

## Key facts

- **NCT ID:** NCT05036837
- **Lead sponsor:** University of Palermo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-02-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** DUE TO PANDEMIC CONDITIONS
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05036837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05036837, "Infiltration of Medical Ozone for the Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05036837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*